$186.85
-2.16-1.14%
Last update: Nov 5, 7:42 PM
AstraZeneca PLC
AZNNYSE
AstraZeneca (AZN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.44 | $1.52 | $1.53 | $2.18 |
| Actual | $2.79 | $2.63 | $2.58 | $2.12 |
| Surprise | +93.8% | +73.0% | +68.6% | -2.75% |
| Revenue | ||||
| Estimate | $16.01B | $15.43B | $14.93B | $15.58B |
| Actual | $16.21B | $15.38B | $15.29B | $15.50B |
| Surprise | +1.22% | -0.27% | +2.40% | -0.49% |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 30, 2026 | $2.79 | $1.44 | 93.8 % |
| Q2 | Jul 27, 2026 | $2.63 | $1.52 | 73.0 % |
| Q1 | Apr 29, 2026 | $2.58 | $1.53 | 68.6 % |
| Q4 | Feb 10, 2026 | $2.12 | $2.18 | -2.75 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 30, 2026 | $16.21B | $16.01B | 1.22 % |
| Q2 | Jul 27, 2026 | $15.38B | $15.43B | -0.27 % |
| Q1 | Apr 29, 2026 | $15.29B | $14.93B | 2.40 % |
| Q4 | Feb 10, 2026 | $15.50B | $15.58B | -0.49 % |
